ASX - Delayed Quote AUD

Microba Life Sciences Limited (MAP.AX)

0.1700
+0.0050
+(3.03%)
At close: May 9 at 1:10:27 PM GMT+10
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
Total Revenue
12,090.0550
12,090.0550
5,420.1360
4,688.6450
Cost of Revenue
6,184.6280
6,184.6280
2,741.8730
2,322.9300
Gross Profit
5,905.4270
5,905.4270
2,678.2630
2,365.7150
Operating Expense
32,748.3380
32,748.3380
22,908.3870
18,637.7790
Operating Income
-26,842.9110
-26,842.9110
-20,230.1240
-16,272.0640
Net Non Operating Interest Income Expense
935.5070
935.5070
817.6370
-5.7380
Other Income Expense
5,917.6150
5,917.6150
6,737.9180
4,816.6030
Pretax Income
-19,989.7890
-19,989.7890
-12,674.5690
-11,461.1990
Tax Provision
-51.3040
-51.3040
5.6430
9.2300
Net Income Common Stockholders
-19,938.4850
-19,938.4850
-12,680.2120
-11,470.4290
Basic EPS
-0.05
--
-0.04
-0.05
Diluted EPS
-0.05
--
-0.04
-0.05
Basic Average Shares
409,858.7840
--
332,990.0810
236,374.9530
Diluted Average Shares
409,858.7840
--
332,990.0810
236,374.9530
Net Income from Continuing & Discontinued Operation
-19,938.4850
-19,938.4850
-12,680.2120
-11,470.4290
Normalized Income
-19,938.4850
-19,938.4850
-12,680.2120
-11,470.4290
Interest Income
1,004.7280
1,004.7280
878.0490
49.5510
Interest Expense
18.5990
18.5990
16.4090
8.3070
Net Interest Income
935.5070
935.5070
817.6370
-5.7380
EBIT
-19,971.1900
-19,971.1900
-12,658.1600
-11,452.8920
EBITDA
-17,100.9160
-17,100.9160
-11,016.3290
-9,910.0300
Reconciled Cost of Revenue
6,184.6280
6,184.6280
2,741.8730
2,322.9300
Reconciled Depreciation
2,870.2740
2,870.2740
1,641.8310
1,542.8620
Net Income from Continuing Operation Net Minority Interest
-19,938.4850
-19,938.4850
-12,680.2120
-11,470.4290
Normalized EBITDA
-17,100.9160
-17,100.9160
-11,016.3290
-9,910.0300
Tax Rate for Calcs
0
0
0.0003
0.0003
Tax Effect of Unusual Items
0
0
0
0
6/30/2022 - 4/5/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GTG.AX Genetic Technologies Limited
0.0390
0.00%
 
PEB.AX Pacific Edge Limited
0.0800
-5.88%
 
IBX.AX Imagion Biosystems Limited
0.0120
-7.69%
 
IIQ.AX INOVIQ Ltd
0.3950
0.00%
 
GSS.AX Genetic Signatures Limited
0.6500
-3.70%
 
MVF.AX Monash IVF Group Limited
0.8350
+1.83%
 
IDX.AX Integral Diagnostics Limited
2.5600
-0.39%
 
HLS.AX Healius Limited
1.1550
-25.00%